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ABSTRACT
Introduction: The BeWEL study is aimed at assessing
the impact of a personalised lifestyle programme on body
weight in people at risk of developing colorectal
adenomas. The study is a two-arm multicentre
randomised controlled trial comparing the BeWEL
lifestyle programme against usual care. Over 12 months,
316 people who have had a colorectal adenoma removed
through the national screening programme will be
randomised to provide 80% power to detect a weight loss
(primary outcome) of 7% over 12 months.
Methods: The 12-month intervention will be delivered
by lifestyle counsellors via three face-to-face visits
followed by nine monthly telephone support calls.
Consultant endorsement for the study will be stressed.
An individualised caloric prescription based on
estimates for weight maintenance 600 kcal will be
calculated. Motivational interviewing techniques will be
used to identify personal motivations for weight change
and ways to improve perceived self-efﬁcacy. The
programme will utilise personalised diet and physical
activity data from baseline measures to set behavioural
goals. A range of behavioural strategies will be
employed to support lifestyle change including goal
setting, identifying speciﬁc implementation intentions,
self-monitoring and feedback. Emphasis will be placed
on self-monitoring body weight, and weighing scales
will be provided. Programme acceptability will be
explored postintervention with indepth interviews.
Compliance and impact will be assessed by baseline and
follow-up measures of diet by self-report, activity by
accelerometry and anthropometry.
Ethics and dissemination: Ethical approval has been
obtained from the Tayside Committee on Medical
Research Ethics. Dissemination of results will focus on
publications in peer-reviewed journals, presentations
at national/international cancer meetings and NHS
groups. In addition, the work will be communicated to
the public through forums such at The Scottish Cancer
Prevention Network (http://www.
cancerpreventionscotland.co.uk/). The trial is
registered with Current Controlled Trials (International
Standard Randomised Controlled Trials No:
ISRCTN53033856).
INTRODUCTION
Colorectal cancer (CRC) is the third most
commonly diagnosed cancer in the UK.
1
Most cases occur in people over 50 years and
CRC often coexists with other diet-related
disorders including obesity, type 2 diabetes
mellitus and cardiovascular disease.
2e4 These
diseases share risk factors related to the
metabolic syndrome including high body
mass index, abnormal lipids and markers of
insulin resistance indicating common aetio-
logical pathways.
5
The World Cancer Research Fund (WCRF)
(2007) review of Food, Nutrition, Physical
Activity and the Prevention of Cancer
provides comprehensive evidence on diet-
and obesity-related risk factors and CRC.
6
The main (convincing level) factors identi-
ﬁed by WCRF to increase risk were high body
fat, red and processed meat and alcohol
intake, whereas high levels of physical activity
and foods containing ﬁbre were factors that
(probably) decreased risk.
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ARTICLE SUMMARY
Article focus
- Design of diet and physical activity intervention
for weight loss.
- Detailed protocol of content and delivery of
intervention.
Key messages
- Process of combining educational, motivational
and behavioural strategies.
- Developing the teachable moment in the colo-
rectal cancer screening setting.
Strengths and limitations of this study
- Minimal contact intervention over 12 months.
- Potential change in control group through study
involvement.
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Open Access ProtocolWeight gain in adulthood is associated with the devel-
opment and recurrence of colorectal adenomas (prema-
lignant lesions), while weight loss is associated with
reduced recurrence rates.
7e9 Therefore, it would seem
prudent to recommend weight loss (through increased
physical activity and dietary adjustment) to overweight
adults who have experienced an adenoma in order to
minimise the risk of CRC and other related co-morbidities.
While surveillance colonoscopy is offered to patients who
have had adenomas, colonoscopy procedures may still
miss adenomas, and several studies have reported interval
cancers diagnosed between examinations.
10e12 Current
evidence suggests that the risk of new adenomas is around
40% after 3 years; although this may be higher in the
morbidly obese.
13 Furthermore, the underlying modiﬁ-
able risk factors that inﬂuence the development of new
adenomas remain after colonoscopy.
The BeWEL study design and evaluation protocol are
described elsewhere.
14 In brief, this is a two-arm, multi-
centre randomised controlled trial comparing the
BeWEL lifestyle programme (targeting behaviour
change with regards to diet, physical activity and weight
loss) against usual care. The intervention will be deliv-
ered over 12 months and aims to achieve complete data
from 266 adults aged 50e74 years who have undergone
colonoscopy for adenoma removal. The primary
outcome is change in body weight.
The behavioural context for the intervention builds on
the observation that programmes which target high-risk
groups are more effective than those targeting the
population at large.
15 In addition, individuals who have
had a health scare (eg, diagnosis of an adenoma) may be
in a ‘teachable moment’ in which they are more moti-
vated to engage with and adhere to lifestyle advice.
16
This may depend on them experiencing an increase in
perceived risk of disease (with expectations of negative
consequences) and having an emotional response that
triggers a redeﬁnition of their self-image or role.
17
The lifestyle goals of the BeWEL intervention were
based on the diabetes prevention trials which have
shown that lifestyle interventions that achieve a weight
loss of 7% of initial body weight and at least 150 min/
week of moderate intensity activity in adults with a body
mass index >25 kg/m
2 reduce the incidence of type 2
diabetes mellitus.
18e21 The behavioural characteristics of
the intervention delivery were largely based on the US
Diabetes Prevention Programme,
22 with the addition of
emphasis on the importance of regular self-weighing
that is widely associated with greater weight loss and
weight prevention.
23 24
The ﬁnal design of the intervention protocol was
informed by formative social marketing research with
the client group,
25 evidence on behaviour change (as
described above) and practical (resource) consider-
ations. The aim of the current paper is to detail the
procedures and content of the lifestyle programme used
with the intervention group as described in the ﬁnal
study protocol.
14
METHODS
The BeWEL study will recruit 316 participants who have
had a colorectal adenoma removed following their
participation in the Scottish Bowel Screening
programme. Of these, 158 (50%) will be randomised to
the intervention arm of the BeWEL trial.
14 The inter-
vention is designed to involve multiple contacts with
Lifestyle Counsellors (LC’s) over a 12-month period, and
all participants will be invited to identify a partner or
friend to provide support. Three face-to-face visits in the
ﬁrst 3 months will be followed with nine telephone
support calls spaced equally until completion of the study
with follow-up assessments being taken at 12 months.
Any serious adverse events (SAEs) experienced by
participants will be reported to the study sponsor, NHS
Tayside Research and Development (administration),
Trial Management Committee, Trial Steering Committee
(TSC), Data Monitoring and Ethics Committee (DMEC)
and the participants’ General Practitioner. In the event
that an SAE is considered to be related to the trial inter-
vention, clinical judgement and the participant’s prefer-
ence will inform any decision whether the participant will
be withdrawn from the trial or may withdraw electively.
Under no circumstances, initiated by the occurrence of
an SAE or otherwise, is a participant permitted to change
group allocation. All SAEs and any consequent decisions
for participant retention are reported appropriately. A
review of all adverse events and SAEs will also be under-
taken at regular intervals by the DMEC to ensure any
differential rate between groups is identiﬁed. Full details
of evaluation methods of the study, for which the primary
outcome is body weight, are provided elsewhere.
14
LCs will be trained to deliver the intervention protocol
that focuses on four strategies for assisting behaviour
change. First, the LCs will aim to increase knowledge
about why the changes are advisable, second, the
magnitude and nature of change required will be
discussed, third, techniques aimed at motivating change
will be used and ﬁnally strategies to improve self-efﬁcacy
about changing diet and activity will be provided.
After providing written informed consent, participants
will undertake their ﬁrst intervention visit. The LCs will
begin their introduction by discussing the process
through which CRC typically develops, that is, the
adenomaecarcinoma sequence.
26 The counsellors will
highlight the importance of diet, activity and body
weight in the prevention of CRC and also emphasise how
weight loss might reduce the risk of other diseases or co-
morbidities. It will then be made clear to participants
that the principal aim of the study is to promote weight
loss through diet and activity. Before addressing speciﬁc
components of the intervention, participants will be
reminded that the changes being promoted are
endorsed by the senior hospital consultants as indicated
in the study invitation letter.
The target goal of a 7% reduction in body weight will be
communicated at the ﬁrst contact. An individualised
energy prescription for weight loss will be identiﬁed in
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BeWEL intervention protocolthree steps. Initially, their requirements for weight main-
tenance will be calculated using Schoﬁeld equations
27
incorporating body weight, gender and age. This will then
be multiplied by their current physical activity level before
a caloric restriction of 600 kcal is applied. The compo-
sition of the diet will be in line with current healthy eating
advice (with caution over consumption of excess red
and processed meat and limiting intake of energy-dense
food and drinks) and increased physical activity. No
pharmacological agents will be provided or promoted.
The general educational components of healthy eating
and active living will initially be explained using the
British Heart Foundation (BHF) (2010) booklet ‘So you
want to lose weight for good’ (which includes the Food
Standards Agency ‘Eatwell’ plate model (the national
food guide).
28 Portion guidance and information on
energy-dense food and drinks (highlighting fast foods
and sugary drinks) will be provided with reference to the
information in the BHF booklet. With respect to physical
activity, demonstrations will be given on ‘brisk walking’
and a pedometer provided for self-monitoring. The
translation of 7% weight loss will be provided as
a personal weight loss target for the 12-month period.
This will include guidance on a personalised 600 kcal
energy-deﬁcit diet (based on estimated Basal Metabolic
Rate), provided on the basis of food group portion sizes
and portion frequencies. Options on following this
completely (eg, starting on 600 kcal) from day 1 or
building up to 600 kcal will be discussed with reference
to the weight loss requirements over a 12-month period.
Motivational interviewing
29 will be utilised to explore
self-assessed conﬁdence, ambivalence and personal values
concerning weight change. A 24-h recall of dietary intake
will be taken to promote discussion around current diet
and allow counsellors to introduce the concept of
personalised dietary change. Study participants will have
worn a SenseWear Pro3 physical activity monitor (Body
Media, Pittsburgh, Pennsylvania, USA) for 7 days to
provide baseline physical activity records (also worn by the
usual care group), prior to being visited by the LC. The
output from the monitors will be utilised to provide
feedback on current activities and to promote discussion
around opportunities to increase leisure time activity
where possible.
To assist change in both diet and physical activity,
participants will be encouraged to focus on one topic
(diet or physical activity) for the remainder of visit one,
and the remaining topic on visit two, generally advising
that the strongest area of existing success is likely to be
the best to begin with. To aid improvements in self-
efﬁcacy, participants will be encouraged to identify
speciﬁc behavioural goals
30 and make short-term speciﬁc
implementation intentions.
31 Success or failure with
these goals will be discussed at follow-up visits. Self-
monitoring will also be encouraged, and participants will
be presented with body weight scales for weekly
weighing, pedometers to monitor daily step counts and
log books. A number of behavioural and re-enforcement
techniques will be employed in this part of the coun-
selling session including tool kits to assist change, prac-
tical discussions on food preparation (or equipment
demonstrations) and self-recording sheets for the
speciﬁc implementation intentions identiﬁed. Tool kits
will include items for loan including kitchen gadgets
such as salad spinners and hand blenders and physical
activity tools such as steppers, hand weights, hula hoops,
exercise DVDs and walking poles. In addition, to
encourage loyalty to the study, all participants will be
given tools with the BeWEL logo: a water bottle to
reinforce the message to reduce sugary drink intake and
a fabric bag for transporting scales home and/or to act
as reminder for healthy eating while shopping.
The ﬁrst session will ﬁnish with a return to weight
matters and instructions for self-monitoring and
recording of weight will be given. Contact details for
professional support will be provided and the next
appointment made. Visits 2 and 3 will have similar
formats, checking well-being discussing and providing
feedback on progress and experiences, exploring areas
of difﬁculty and providing encouragement. Visit 2 will
also encourage a focus on the second topic area (diet or
activity) not selected in visit 1. The content of all visits is
presented in table 1.
By the end of visit 3, all participants will have identiﬁed
a speciﬁc set of personalised diet and activity imple-
mentation intentions and weight loss goals for the
remainder of the study.
The remainder of the intervention will be delivered by
telephone (table 2). Nine further telephone calls from 3
to 12 months will be completed before participants
return to the research centre for follow-up measures.
LCs will continue to support BeWEL participants in their
attempts to lose the target 7% body weight. Participants
who do achieve this target but who remain overweight
will be encouraged to continue the weight loss
programme. Participants who have met their target
weight loss (and are no longer overweight) will be
encouraged to adopt a weight maintenance approach.
Follow-up calls will begin with a general introduction
about mental and physical well-being, and LC’s will
attempt to elicit participant’s views on making lifestyle
change. LC’s will be responsible for checking partici-
pant’s progress since visit 3 and the ﬁrst follow-up at
3 months, discussing areas of success and difﬁculty. LC’s
will provide the participant with further verbal (and
where appropriate written) and personalised lifestyle
advice to promote optimal dietary intake, physical
activity and weight loss. Personalised goals will be agreed
and updated through discussion with the participant,
and the LC’s will keep records of these to provide
personalised feedback and continuity through to follow-
up at 12 months.
Protocol adherence and monitoring
LCs will keep participant notes recording the application
of the above procedures, and these will be reported to
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BeWEL intervention protocolTable 1 Delivery and content of counsellor visits (contacts 1e3)
Visit 1 Visit 2 Visit 3
Contact Face-to-face Face-to-face Face-to-face
Time line Following baseline
assessment
Week 6e8 3 months
Duration 90 min 45 min 45 min
Who delivers Trained counsellor Trained counsellor Trained counsellor
Intervention
location
Home/research centre Home/research centre Home/research centre
Social support Invited friend/partner/
family member
Invited friend/partner/
family member
Invited friend/partner/
family member
Introduction < Check nurse
assessment
< Importance of
lifestyle change
< Consultant endorsement
< Identify 12-month weight
loss target
< Current well-being
< Experience of making
change
< Importance of modest
change
< Building towards
12-month weight
loss target
< Current well-being
< Experience of making
change
< Importance of modest
change
< Building towards
12-month weight loss target
Motivational
approaches
24-h dietary recall/activity
assessment
< Identify perceived
diet/activity challenges
< Identify self-assessed
motivations, conﬁdence,
ambivalence and personal
value regarding weight
change
Identify self-monitored
weight
< Provide feedback
< Provide encouragement
< Identify self-assessed
motivations, conﬁdence,
ambivalence and personal
values rechange
Identify self-monitored weight
< Provide feedback
< Provide encouragement
< Identify conﬁdence and
support needs
Educationd
general
Healthy eating and activity
principles
< Portion size
< Energy-dense food and
drinks
< Breakfast meals and
snacks
< Activity and inactivity
< Demonstration of brisk
walking + pedometer
Discuss experience of
changing diet and activity
referring back to perceived
challenges at visit 1.
Check for queries or areas
of confusion or elaboration
Discuss walking + pedometer
Discuss experience of changing
diet and activity referring back
to perceived challenges at
visits 1 and 2
Check for queries or areas of
confusion or elaboration
Discuss walking + pedometer
Educationd
personalised
Structured weight loss
programme  600 kcal
diet prescription plan
Discuss progress towards
achieving  600 kcal diet
Discuss progress towards
achieving  600 kcal diet
Behavioural
and
re-enforcement
techniques
DIET OR
ACTIVITY
Introduce diet or activity
focus 1
Discuss self-monitoring
of focus 1
Provide positive feedback
Identify challenges
Discuss maintenance
Introduce diet or activity
focus 2
Discuss self-monitoring of
focus 2
Provide positive feedback
Identify challenges
Discuss maintenance of
foci 1 and 2
Negotiate key long-term diet
and activity goals based on:
Perceived achievements
Summarise success
Behavioural and
re-enforcement
techniques
WT MANAGEMENT
Provide body weight scales
Explanation of self-monitoring
procedures
Remind about 12-month goal
Re-enforce body weight
techniques
Check body weight scales
and the need for continued
monitoring
Professional support Provide tel and email contact
details
Identify next two appointments
Conﬁrm next appointment
and identify date for call 1
Conﬁrm call 1 and identify
date for call 2
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BeWEL intervention protocolthe study team as an indirect check on intervention
ﬁdelity and to encourage protocol adherence. Regular
meetings will be held with all counsellors to discuss
challenges in protocol adherence and possible solutions
to address problems, which will be re-assessed at follow-
up workshops. A protocol minor amendment has also
enabled approval to be given for research team members
to be present at face-to-face intervention sessions and to
record telephone counselling.
Programme acceptability will be explored after inter-
vention with indepth exit interviews (undertaken by staff
not involved with programme delivery) with a random
sample of 30 intervention participants. Interviews will
cover participants’ initial expectations and motivations
regarding the programme, the extent to which these
were met or not by their subsequent experiences and
factors inﬂuencing their ability to make the recom-
mended lifestyle changes.
14 A thematic analysis of
interview transcripts will be undertaken, exploring such
themes as what factors inﬂuence decisions to engage in
the programme, how uptake is inﬂuenced by socio-
economic status, the practical barriers and opportunities
for facilitating physical activities and changes in dietary
habits and the perceived acceptability of the programme
to participants and families.
The impact of speciﬁc component parts on outcomes
will not be assessed, but reported compliance with diet
and physical activity goals will be available from post-
intervention measures.
14
ETHICS AND DISSEMINATION
Ethical approval for the intervention content was obtained
from the Tayside Committee on Medical Research Ethics.
Financial support is provided by the National Preven-
tion Research Initiative (http://www.npri.org.uk), grant
award number G0802030. National Prevention Research
Initiative is a national research initiative administered
by the Medical Research Council made up of the
following funding partners: Alzheimer’s Research Trust;
Alzheimer’s Society; Biotechnology and Biological
Sciences Research Council; Cancer Research UK; Chief
Scientist Ofﬁce, Scottish Government Health Directorate;
Department of Health; Diabetes UK; Economic and Social
Research Council; Engineering and Physical Sciences
Research Council; Health & Social Care Research &
Development Ofﬁce for Northern Ireland; Medical
Research Council; Welsh Assembly Government and
WCRF. In addition, further ﬁnancial support is also being
provided by the NHS Research Scotland to carry out this
work. The study is sponsored by the University of Dundee.
Governance for the study is provided by a TSC with an
independent Chairperson, representatives from other
academic institutions, non-governmental organisations
(NGO), patient representatives and representatives from
the sponsor and funding agency. However, decisions on
study design, protocol amendments, data collection,
management, analysis and data interpretation, publica-
tion policy and report writing and submission are made
by the Trial Management Committee subject to approval
by TSC aided by an independent DMEC.
The detailed intervention protocol provides a stand-
ardised approach to intervention design, delivery and
content for use in diet, physical activity and weight loss
trials. The rationale for the total amount of contact time
(5.25 h over a 12-month period) with counsellors would
be similar to monthly weight management
Table 2 Telephone intervention for contacts 4e12
Contacts 4e12
Contact Telephone
Time line Following on from third face-to-face contact until 12-month follow-up
assessment
Duration 10e15 min
Who delivers Trained counsellor
Introduction General exchange about mental and physical health
Elicit participant’s overview on progress and change made
Re-enforce importance of modest behaviour change for health beneﬁt
Importance of change and building towards 12-month weight loss target.
3 months gone but 9 months to continue improvement.
Motivational approaches Check self-monitoring records
Identify perceived diet/activity challenges
Identify self-assessed motivations, conﬁdence, ambivalence and personal
value reweight change
Informing change Re-enforce portion size guidance/energy-dense foods/energy-dense drinks
Importance of remaining active
Personal goals (implementation intentions) Continue to focus on short-term implementation intentions and review these
at next call.
Setting long-term goals Identify perceived achievements and summarise success
Re-evaluate conﬁdence, motivation and importance of changes made
Professional support Make appointment for next telephone call but reiterate you can respond to
questions before this call as they arise.
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BeWEL intervention protocolappointments in NHS (primary care) but less than
commercial slimming clubs. Minimal contact enables
costs to be minimised but professional support to be
retained.
Group work was not considered because of the
geographical spread of the regions in which the trial is
being carried out and the subject face-to-face time
burden. Minimal contact approaches such as phone and
email have been shown to produce promising results for
weight loss with high-frequency calls from a health
professional producing similar results to high-frequency
face-to-face lifestyle modiﬁcation counselling.
32 33
The content of the intervention was based on current
guidelines for weight management from the Scottish
Intercollegiate Guidelines Network
34 that recommends
a combination of physical activity, diet and behavioural
therapy components. The behavioural strategies used
draw on evidence for successful dietary changes from
Ammerman et al
35 and weight loss management from the
National Institute for Health and Clinical Excellence.
36
The ﬁdelity of the intervention content and delivery
will inevitably vary by the individual style of each LC, but
training sessions have emphasised the need to deliver all
components but modify to suit the participants’ indi-
vidual circumstances, for example, disability, economic
circumstances or learning difﬁculties. While family/
friend support is recommended, it is recognised that this
will not be possible to access in all cases.
The ease of undertaking all contacts with participants,
delivering the intervention components and feedback
from participants will provide insight to the practical
acceptability of this theory-based practice-focused inter-
vention design.
The dissemination of the trial ﬁndings will principally
be carried out through publications in peer-reviewed
journals, presentations at national/international cancer-
focused meetings and to NHS groups including the
Scottish Cancer Task Force. In addition, the work will be
communicated to the public through forums such at
The Scottish Cancer Prevention Network (http://www.
cancerpreventionscotland.co.uk/).
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editing.
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